Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 6/20 | 0.62 |
| ▸ | DRD3 | P35462 | 5/20 | 0.62 |
| ▸ | HTR2C | P28335 | 3/20 | 0.49 |
| ▸ | DRD4 | P21917 | 3/20 | 0.48 |
| ▸ | HTR1A | P08908 | 4/20 | 0.48 |
| ▸ | HTR7 | P34969 | 3/20 | 0.48 |
| ▸ | HTR2A | P28223 | 2/20 | 0.48 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.45 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9197199 | 1.00 | DRD2 (0.62) | DRD2DRD3HTR2CDRD4HTR1A | |
| SCHEMBL9197201 | 1.00 | DRD2 (0.62) | DRD2DRD3HTR2CDRD4HTR1A | |
| SCHEMBL9199103 | 0.90 | DRD2 (0.49) | DRD2DRD3HTR2CDRD4HTR2A | |
| SCHEMBL9199108 | 0.90 | DRD2 (0.49) | DRD2DRD3HTR2CDRD4HTR2A | |
| SCHEMBL9199099 | 0.90 | DRD2 (0.49) | DRD2DRD3HTR2CDRD4HTR2A | |
| SCHEMBL9202816 | 0.86 | DRD2 (0.55) | DRD2DRD3HTR2CDRD4HTR1A | |
| SCHEMBL9196526 | 0.84 | DRD2 (0.59) | DRD2DRD3HTR2CDRD4HTR1A | |
| SCHEMBL9195870 | 0.84 | DRD2 (0.59) | DRD2DRD3HTR2CDRD4HTR1A | |
| SCHEMBL9196967 | 0.83 | DRD2 (0.53) | DRD2DRD3HTR2CDRD4HTR1A | |
| SCHEMBL9367382 | 0.82 | KDM4E (0.45) | HTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0431580-B1 | Substituted cyclohexanols as central nervous system agents | WARNER LAMBERT CO (US) | 1995-03-08 | — | — | EP | claimed |
| EP-0431580-A2 | Substituted cyclohexanols as central nervous system agents | WARNER-LAMBERT COMPANY (US) | 1991-06-12 | — | — | EP | claimed |
| EP-0431580-B1 | Substituted cyclohexanols as central nervous system agents | WARNER LAMBERT CO (US) | 1995-03-08 | — | — | EP | disclosed |
| US-5047406-A | Substituted cyclohexanols as central nervous system agents | WARNER-LAMBERT CO. (US) | 1991-09-10 | — | — | US | disclosed |
| EP-0431580-A2 | Substituted cyclohexanols as central nervous system agents | WARNER-LAMBERT COMPANY (US) | 1991-06-12 | — | — | EP | disclosed |
| EP-0431579-A2 | Substituted cyclohexenes as central nervous system agents | WARNER-LAMBERT COMPANY (US) | 1991-06-12 | — | — | EP | disclosed |
| US-4975445-A | Antidepressants | WARNER-LAMBERT COMPANY (US) | 1990-12-04 | — | — | US | disclosed |
| US-4957921-A | Substituted cyclohexanols as central nervous system agents | WARNER-LAMBERT COMPANY (US) | 1990-09-18 | — | — | US | disclosed |